Company profile
Kestra Medical Technologies, Ltd.
NASDAQ: KMTS · Healthcare · Medical - Instruments & Supplies
#412 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ 12GM —SS 56
v0.1 · 25/100 weight · pillars only
↑ Altman-Z, revenue growth (YoY) · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$106.7M
Rev growth YoY (TTM)
+60.7%
Net income (FY)
-$113.8M
Employees
443
as of 2026-09-10
Market cap
$1.4B
as of 2026-09-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$59.8M$59.8M2025
Net income-$113.8M-$113.8M2025
Operating income-$106.4M-$106.4M2025
Total assets$295.7M$295.7M2025
Liabilities$90.3M$90.3M2025
Equity$205.4M$205.4M2025
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Kestra Medical Technologies, Ltd.’s revenue?
Kestra Medical Technologies, Ltd. booked $59.8M in FY2025 revenue, growing 115% year over year — faster than most Healthcare companies we track, at a -190.3% net margin.
Peers · Healthcare
Tango Therapeutics, Inc.55CJourney Medical Corporation52DFortress Biotech, Inc.62CEtao International Co., Ltd.——Flower One Holdings Inc.——Champions Oncology, Inc.——Neighbors
King →Key facts
CEOBrian Webster
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersKirkland, WA
ExchangeNASDAQ: KMTS
Employees443
IPO date2025-03-06
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.